Keywords: Celgene, Financial results ,Fourth-quarter and full-year 2012

Celgene post strong sales and earnings performance

Article | 25 January 2013

US biotech company Celgene (Nasdaq: CELG) yesterday reported net product sales of $1.42 billion for the fourth quarter 2012, a 14% increase from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Celgene

Go to company listing